Medication class | Example | Mechanism of action |
---|---|---|
Nitric oxide modulators | (i) Nitrates | (i) Vasodilation induced by nitrates through activation of the guanylyl cyclase signaling pathway (endothelium-dependent) |
| ||
Alpha-blockers | (i) Doxazosin | (i) Sympatholytic capacity which causes a reduction in the microvascular tone (endothelium-dependent) |
| ||
Novel antianginal | (i) Ranolazine | (i) Inhibiting late sodium current in cardiomyocytes (ii) Improving endothelial function (endothelium-dependent) |
| ||
Miscellaneous | (i) Trimetazidine | (i) Inhibiting the long-chain of 3-ketoacyl coenzyme A thiolase |
(ii) Thiazolidinediones | (i) Improving endothelial dysfunction through modulation of oxidative processes (endothelium-independent) | |
(iii) Xanthine derivatives | (i) Vasodilation (endothelium-dependent) (ii) Mediating ischemic pain perception |
NO: nitric oxide; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blockers; NADPH: nicotinamide adenine dinucleotide phosphate; SGLT: sodium-glucose cotransporter; NAC: N-acetylcysteine.